Skip to main content

FIELD GRAND CHALLENGE article

Front. Virol., 25 March 2021
Volume 1 - 2021 | https://doi.org/10.3389/fviro.2021.665473

Frontiers in Virology: An Innovative Platform for Integrative Virus Research

  • Department of Microbiology, Kansai Medical University, Osaka, Japan

Since the first discovery of a plant virus in 19th century, numerous viruses have been found and identified as admirably unique genetic agents in virtually all unicellular and multicellular living creatures (13) (Figure 1). They are parasitic entities that replicate in a remarkably different manner in their specific hosts. Owing to extensive and enthusiastic efforts to date by numbers of scientists in diverse research fields, viruses are now recognized to be the most abundant replicating species in nature. However, naturally occurring viruses are found to be beyond the scope of our expectations. Each viral species has its own unique strategy to interact with its host species for survival and frequently gives unexpected results upon its infection, representing a wide variety of scientifically important biological issues to be addressed and solved (1, 426). Furthermore, new dreadful pathogenic viruses with distinct characteristics keep emerging or reemerging in various parts of the world, generating significant menaces to humans (4, 10, 2734). It is thus increasingly important to systemically explore viruses in detail particularly in this challenging time (29, 32, 3436) (Figure 1). Viral infectious diseases are certainly one of the most critical issues in medical, environmental, ecological, and health sciences. Extensive efforts need to be made against these pathogenic viruses. Today's virology, at a global level, aims at understanding practical aspects of viruses as well as elucidating relevant biological basic matters (Figure 1).

FIGURE 1
www.frontiersin.org

Figure 1. Concept of contemporary virology. A wide variety of viruses/virus hosts (bottom) and numbers of scientific materials/methodologies/technologies for studies on viruses (middle) are depicted. At the top, an imaginary and desirable time course of viral disease distribution (pandemic) is illustrated. One clear and definitive goal of integrative virology in the era of recurringly emerging viruses is certainly to overcome the threat they pose to our world. Courtesy of Drs. Takaaki Koma and Masako Nomaguchi of Tokushima University, Tokushima, Japan.

Virology has gradually developed to the present multidisciplinary status from the initial stage 130 years ago. During the period, virology clearly has been acting as strong driving forces to make paradigm shifts for basic biology and molecular biology (13), and also for applied sciences of various fields including nanotechnology, virus vectors, and medical therapies (3739). Viruses are the smallest and most simple organic molecules with highly ordered structures that can replicate as a population under some specific conditions. On one hand, viruses are sometimes pathogenic/fatal for their hosts and sometimes transmittable among different host species. Targeting and taking the advantage of these characteristic viruses, a number of highly memorable investigations on biology and medicine, Nobel prize and Nobel prize-worthy studies, have been performed as well-known. Invaluable studies on various viruses are currently in progress all over the world. Needless to mention, the development and success of current virology have been critically supported by the innovative next-generation methodologies/technologies recently available. These include the forefront systems, such as bioinformatics, modellings, and sequencings, to sensitively and precisely analyze the concerned issues (3, 18, 4056) (Figure 1). Given the multi-faceted perspective and inherent thoroughness, results obtained by these methods would readily point out the next projects to be done. We virologists can now predict, albeit to a certain degree, how viruses behave in response to environmental changes and are able to verify the predicted outcomes in an open and demonstrative way by well-designed experiments (13). Virology should spread its wings to be more scientifically general and inspirational, and should also continue to be a major academic discipline of the biology.

Frontiers in Virology actively reports all the scientifically critical investigations/efforts relevant to all kinds of viruses in nature (Figure 1). It publishes high-quality studies on all species and topics of viruses in one journal in an integrative manner. It surely impacts both academic and public communities by eminent methodologies/technologies used for studies as well as crucial scientific contents reported. On one hand, as repeatedly emphasized and stated above, viruses are beyond the scope of our expectations. We virologists must keep exploring the nature of viruses by in-depth analytical studies. We do not understand the viruses themselves as yet to a sufficient extent for various biological and molecular biological points. In contrast, unfortunately, we certainly know that there are highly invasive and pathogenic viruses in our environments. It is becoming more likely that humans may experience new viral diseases caused by some emerging zoonotic viruses (an awful pandemic in the worst case), if we think about the world's environmental situation today. Also in this regards, it is pivotal for us virologists to stare at these mysterious viruses from diversified standpoints to really grasp their essentials. Toward this end, we have constructed a united cooperative platform for scientific information and interaction in the rapidly growing virology field. In order to effectively share, explore, and discuss about new findings, Frontiers in Virology consists of 10 distinct unique specialties, that is, “Fundamental virology,” “Bioinformatic and predictive virology,” “Virus and host immunity,” “Antivirals and vaccines,” “Emerging and reemerging viruses,” “Viral diversification and evolution,” “Translational virology,” “Viral disease investigation,” “Systems virology,” and “Modeling of viral replication and pathogenesis.” Summaries, keywords, and focuses for each section are as follows.

Fundamental Virology

All basic issues related to various viruses, biology and molecular biology, virus replication, structural and functional virology, viral genetics, chemistry, classification.

Bioinformatic and Predictive Virology

Experimental and computational sciences, informatics, in silico studies, homology modeling, MD simulation, theoretical virology, predictive virology.

Virus and Host Immunity

Host immunity against viruses, recognition of viruses by hosts, interaction between host and virus, viral escape mutations from host immunity, viral pathogenesis.

Antivirals and Vaccines

Study and development of effective anti-viral drugs and vaccines, effects of the drugs and vaccines on individuals and the populations, anti-viral treatments.

Emerging and Reemerging Viruses

All issues (basic and applied) related to emerging and re-emerging viruses, adaptation and evolution of the viruses, description of new viruses in detail.

Viral Diversification and Evolution

Viral mutation, viral adaptation, viral evolution, viral diversity with respect to replication property and biological properties such as pathogenicity, population genetics.

Translational Virology

Applied medical sciences based on significant results/findings of basic virology, future perspective, description of (new) systems for the translational research in detail.

Viral Disease Investigation

All issues related to various viral diseases, pandemics, medical studies, pre-clinical and clinical studies, pathophysiology of viral diseases, persistent infection.

Systems Virology

Innovative research systems, novel technologies/methodologies, experimental/demonstrative studies based on innovative research systems/technologies/methodologies.

Modeling of Viral Replication and Pathogenesis

In vitro model studies, animal models for viral replication and pathogenicity, organoid models for virus infections, any model systems for viral replication and viral diseases.

Finally, we encourage all active researchers, who are experts in virology and also who are not experts in virology but are specially or specifically interested in the research area or the particular theme, to submit the best works to the most fitted section in Frontiers in Virology. We are sincerely looking forward to receiving field-moving scientific articles. Please join us contributing to the promotion and development of scientific interplay in virology and to the successful fight against viral diseases.

Author Contributions

AA is a sole contributor to this manuscript and approved its submission.

Conflict of Interest

The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

I would like to thank Masako Nomaguchi and Takaaki Koma (Tokushima University, Tokushima, Japan) for continuous hot and extensive discussions about Virology. I am awfully indebted to them for conceptualizing and drawing of Figure 1. I also appreciate Fumie Nishina (Kansai Medical University, Osaka, Japan) and Kazuko Yoshida (Tokushima University) for excellent editorial assistance.

References

1. Nomaguchi M, and Adachi A. Virology as biosystematics: towards understanding the viral infection biology. Front Microbiol. (2010) 1:2. doi: 10.3389/fmicb.2010.00002

CrossRef Full Text | Google Scholar

2. Sanfaçon H. Grand challenge in plant virology: understanding the impact of plant viruses in model plants, in agricultural crops, and in complex ecosystems. Front Microbiol. (2017) 8:860. doi: 10.3389/fmicb.2017.00860

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Adachi A. Grand challenge in human/animal virology: unseen, smallest replicative entities shape the whole globe. Front Microbiol. (2020) 11:431. doi: 10.3389/fmicb.2020.00431

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Nomaguchi M, and Adachi A. Editorial: highly mutable animal RNA viruses: adaptation and evolution. Front Microbiol. (2017) 8:1785. doi: 10.3389/fmicb.2017.01785

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Nomaguchi M, Fujita M, Miyazaki Y, and Adachi A. Viral tropism. Front Microbiol. (2012) 3:281. doi: 10.3389/fmicb.2012.00281

CrossRef Full Text | Google Scholar

6. Tsunetsugu-Yokota Y, and Terahara K. Receptor usage and the pathogenesis in acute and chronic virus infections. Front Microbiol. (2012) 3:289. doi: 10.3389/fmicb.2012.00289

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Ueda K. For the future studies of Kaposi's sarcoma-associated herpesvirus. Front Microbiol. (2012) 3:237. doi: 10.3389/fmicb.2012.00237

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Flores R, Moreno P, Falk B, Martelli GP, and Dawson WO. e-Book on Closteroviridae. Front Microbiol. (2013) 4:411. doi: 10.3389/fmicb.2013.00411

CrossRef Full Text | Google Scholar

9. Koito A, and Ishizaka Y. Retroviruses, retroelements and their restrictions. Front Microbiol. (2013) 4:197. doi: 10.3389/fmicb.2013.00197

CrossRef Full Text | Google Scholar

10. Adachi A, and Miura T. Animal model studies on viral infections. Front Microbiol. (2014) 5:672. doi: 10.3389/fmicb.2014.00672

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Chan S-W. The unfolded protein response in virus infections. Front Microbiol. (2014) 5:518. doi: 10.3389/fmicb.2014.00518

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Kimura H, and Ryo A. Pathophysiology and epidemiology of virus-induced asthma. Front Microbiol. (2014) 5:562. doi: 10.3389/fmicb.2014.00562

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Laguette N, and Benkirane M. Shaping of the host cell by viral accessory proteins. Front Microbiol. (2015) 6:142. doi: 10.3389/fmicb.2015.00142

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Mahony J, and van Sinderen D. Gram-positive phage-host interactions. Front Microbiol. (2015) 6:61. doi: 10.3389/fmicb.2015.00061

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Suzuki N, Sasaya T, and Choi IR. Editorial: viruses threatening stable production of cereal crops. Front Microbiol. (2015) 6:470. doi: 10.3389/fmicb.2015.00470

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Aherfi S, Colson P, La Scola B, and Raoult D. Giant viruses of amoebas: an update. Front Microbiol. (2016) 7:349. doi: 10.3389/fmicb.2016.00349

CrossRef Full Text | Google Scholar

17. Atluri VSR. Editorial: HIV and illicit drugs of abuse. Front Microbiol. (2016) 7:221. doi: 10.3389/fmicb.2016.00221

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Rakonjac J, Das B, and Derda R. Editorial: filamentous bacteriophage in bio/nano/technology, bacterial pathogenesis and ecology. Front Microbiol. (2016) 7:2109. doi: 10.3389/fmicb.2016.02109

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Liu J-Z, Li F, and Liu Y. Editorial: plant immunity against viruses. Front Microbiol. (2017) 8:520. doi: 10.3389/fmicb.2017.00520

CrossRef Full Text | Google Scholar

20. Bertazzoni U, Ciminale V, and Romanelli MG. Editorial: molecular pathology of HTLV-1. Front Microbiol. (2018) 9:3069. doi: 10.3389/fmicb.2018.03069

CrossRef Full Text | Google Scholar

21. Martinez-Salas E, Francisco-Velilla R, Fernandez-Chamorro J, and Embarek AM. Insights into structural and mechanistic features of viral IRES elements. Front Microbiol. (2018) 8:2629. doi: 10.3389/fmicb.2017.02629

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Ziv C, Zhao Z, Gao YG, and Xia Y. Multifunctional roles of plant cuticle during plant-pathogen interactions. Front Plant Sci. (2018) 9:1088. doi: 10.3389/fpls.2018.01088

PubMed Abstract | CrossRef Full Text | Google Scholar

23. Dobnik D, Kogovšek P, Jakomin T, Košir N, Tušek Žnidarič M, Leskovec M, et al. Accurate quantification and characterization of adeno-associated viral vectors. Front Microbiol. (2019) 10:1570. doi: 10.3389/fmicb.2019.01570

PubMed Abstract | CrossRef Full Text | Google Scholar

24. Nasir A, Caetano-Anollés G, and Claverie JM. Editorial: viruses, genetic exchange, and the tree of life. Front Microbiol. (2019) 10:2782. doi: 10.3389/fmicb.2019.02782

PubMed Abstract | CrossRef Full Text | Google Scholar

25. Rooney BV, Crucian BE, Pierson DL, Laudenslager ML, and Mehta SK. Herpes virus reactivation in astronauts during spaceflight and its application on earth. Front Microbiol. (2019) 10:16. doi: 10.3389/fmicb.2019.00016

PubMed Abstract | CrossRef Full Text | Google Scholar

26. Sumbria D, Berber E, and Rouse BT. Factors affecting the tissue damaging consequences of viral infections. Front Microbiol. (2019) 10:2314. doi: 10.3389/fmicb.2019.02314

PubMed Abstract | CrossRef Full Text | Google Scholar

27. Nakayama E, and Saijo M. Animal models for Ebola and Marburg virus infections. Front Microbiol. (2013) 4:267. doi: 10.3389/fmicb.2013.00267

PubMed Abstract | CrossRef Full Text | Google Scholar

28. Saiz JC, Vázquez-Calvo Á, Blázquez AB, Merino-Ramos T, Escribano-Romero E, and Martín-Acebes MA. Zika virus: the latest newcomer. Front Microbiol. (2016) 7:496. doi: 10.3389/fmicb.2016.00496

CrossRef Full Text | Google Scholar

29. Bueno-Marí R, Saiz J-C, Salomón OD, Villamil-Jiménez LC, Heukelbach J, Alencar C H, et al. Editorial: Zika virus research. Front Neurol. (2018) 9:168. doi: 10.3389/fneur.2018.00168

CrossRef Full Text | Google Scholar

30. Xu S, Li X, Yang J, Wang Z, Jia Y, Han L, et al. Comparative pathogenicity and transmissibility of pandemic H1N1, avian H5N1, and human H7N9 influenza viruses in tree shrews. Front Microbiol. (2019) 10:2955. doi: 10.3389/fmicb.2019.02955

PubMed Abstract | CrossRef Full Text | Google Scholar

31. Yong CY, Ong HK, Yeap SK, Ho KL, and Tan WS. Recent advances in the vaccine development against Middle East respiratory syndrome-coronavirus. Front Microbiol. (2019) 10:1781. doi: 10.3389/fmicb.2019.01781

PubMed Abstract | CrossRef Full Text | Google Scholar

32. Koma T, Adachi S, Doi N, Adachi A, and Nomaguchi M. Toward understanding molecular bases for biological diversification of human coronaviruses: present status and future perspectives. Front Microbiol. (2020) 11:2016. doi: 10.3389/fmicb.2020.02016

PubMed Abstract | CrossRef Full Text | Google Scholar

33. Larsen JR, Martin MR, Martin JD, Kuhn P, and Hicks JB. Modeling the onset of symptoms of COVID-19. Front Public Health. (2020) 8:473. doi: 10.3389/fpubh.2020.00473

PubMed Abstract | CrossRef Full Text | Google Scholar

34. Mercatelli D, and Giorgi FM. Geographic and genomic distribution of SARS-CoV-2 mutations. Front Microbiol. (2020) 11:1800. doi: 10.3389/fmicb.2020.01800

PubMed Abstract | CrossRef Full Text | Google Scholar

35. Tse LV, Meganck RM, Graham RL, and Baric RS. The current and future state of vaccines, antivirals and gene therapies against emerging coronaviruses. Front Microbiol. (2020) 11:658. doi: 10.3389/fmicb.2020.00658

PubMed Abstract | CrossRef Full Text | Google Scholar

36. Wang N, Shang J, Jiang S, and Du L. Subunit vaccines against emerging pathogenic human coronaviruses. Front Microbiol. (2020) 11:298. doi: 10.3389/fmicb.2020.00298

PubMed Abstract | CrossRef Full Text | Google Scholar

37. Szunerits S, Barras A, Khanal M, Pagneux Q, and Boukherroub R. Nanostructures for the inhibition of viral infections. Molecules. (2015) 20:14051–81. doi: 10.3390/molecules200814051

CrossRef Full Text | Google Scholar

38. Athanasopoulos T, Munye MM, and Yáñez-Muñoz RJ. Nonintegrating gene therapy vectors. Hematol Oncol Clin North Am. (2017) 31:753–70. doi: 10.1016/j.hoc.2017.06.007

CrossRef Full Text | Google Scholar

39. Graham BS, Gilman MSA, and McLellan JS. Structure based vaccine antigen design. Annu Rev Med. (2019) 70:91–104. doi: 10.1146/annurev-med-121217-094234

PubMed Abstract | CrossRef Full Text | Google Scholar

40. Miyazaki Y, Fujita M, Nomaguchi M, and Adachi A. Structural biology for virus research. Front Microbiol. (2012) 3:91. doi: 10.3389/fmicb.2012.00091

PubMed Abstract | CrossRef Full Text | Google Scholar

41. Sato H, Yokoyama M, and Toh H. Genomics and computational science for virus research. Front Microbiol. (2013) 4:42. doi: 10.3389/fmicb.2013.00042

PubMed Abstract | CrossRef Full Text | Google Scholar

42. Bai XC, McMullan G, and Scheres SH. How cryo-EM is revolutionizing structural biology. Trends Biochem Sci. (2015) 40:49–57. doi: 10.1016/j.tibs.2014.10.005

CrossRef Full Text | Google Scholar

43. Angermueller C, Pärnamaa T, Parts L, and Stegle O. Deep learning for computational biology. Mol Syst Biol. (2016) 12:878. doi: 10.15252/msb.20156651

CrossRef Full Text | Google Scholar

44. Chen C, Huang H, and Wu C. Protein bioinformatics databases and resources. Methods Mol Biol. (2017) 1558:3–39. doi: 10.1007/978-1-4939-6783-4_1

CrossRef Full Text | Google Scholar

45. Dutilh BE, Reyes A, Hall RJ, and Whiteson KL. Editorial: virus discovery by metagenomics: the (im)possibilities. Front Microbiol. (2017) 8:1710. doi: 10.3389/fmicb.2017.01710

PubMed Abstract | CrossRef Full Text | Google Scholar

46. Dutta D, Heo I, and Clevers H. Disease modeling in stem cell-derived 3D organoid systems. Trends Mol Med. (2017) 23:393–410. doi: 10.1016/j.molmed.2017.02.007

PubMed Abstract | CrossRef Full Text | Google Scholar

47. Hasin Y, Seldin M, and Lusis A. Multi-omics approaches to disease. Genome Biol. (2017) 18:83. doi: 10.1186/s13059-017-1215-1

CrossRef Full Text | Google Scholar

48. Yamamoto T, Honda A, Sato T, and Ryo A. Editorial: perspectives for the next generation of virus research: spearheading the use of innovative technologies and methodologies. Front Microbiol. (2017) 8:758. doi: 10.3389/fmicb.2017.00758

PubMed Abstract | CrossRef Full Text | Google Scholar

49. Adli M. The CRISPR tool kit for genome editing and beyond. Nat Commun. (2018) 9:1911. doi: 10.1038/s41467-018-04252-2

PubMed Abstract | CrossRef Full Text | Google Scholar

50. Artegiani B, and Clevers H. Use and application of 3D-organoid technology. Hum Mol Genet. (2018) 27:R99–R107. doi: 10.1093/hmg/ddy187

CrossRef Full Text | Google Scholar

51. Cheng Y. Membrane protein structural biology in the era of single particle cryo-EM. Curr Opin Struct Biol. (2018) 52:58–63. doi: 10.1016/j.sbi.2018.08.008

PubMed Abstract | CrossRef Full Text | Google Scholar

52. Ibrahim B, McMahon DP, Hufsky F, Beer M, Deng L, Mercier PL, et al. A new era of virus bioinformatics. Virus Res. (2018) 251:86–90. doi: 10.1016/j.virusres.2018.05.009

CrossRef Full Text | Google Scholar

53. Rossi G, Manfrin A, and Lutolf MP. Progress and potential in organoid research. Nat Rev Genet. (2018) 19:671–87. doi: 10.1038/s41576-018-0051-9

PubMed Abstract | CrossRef Full Text | Google Scholar

54. Sbalzarini IF, and Greber UF. How computational models enable mechanistic insights into virus infection. Methods Mol Biol. (2018) 1836:609–31. doi: 10.1007/978-1-4939-8678-1_30

PubMed Abstract | CrossRef Full Text | Google Scholar

55. van Dijk EL, Jaszczyszyn Y, Naquin D, and Thermes C. The third revolution in sequencing technology. Trends Genet. (2018) 34:666–81. doi: 10.1016/j.tig.2018.05.008

CrossRef Full Text | Google Scholar

56. Pickar-Oliver A, and Gersbach CA. The next generation of CRISPRCas technologies and applications. Nat Rev Mol Cell Biol. (2019) 20:490–507. doi: 10.1038/s41580-019-0131-5

CrossRef Full Text | Google Scholar

Keywords: virology, biology, naturally occurring viruses, pathogenic viruses, emerging viruses, viral diseases, pandemic

Citation: Adachi A (2021) Frontiers in Virology: An Innovative Platform for Integrative Virus Research. Front. Virol. 1:665473. doi: 10.3389/fviro.2021.665473

Received: 08 February 2021; Accepted: 12 February 2021;
Published: 25 March 2021.

Edited and reviewed by: Mario Mago Clerici, University of Milan, Italy

Copyright © 2021 Adachi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Akio Adachi, adachi@tokushima-u.ac.jp; adachiak@hirakata.kmu.ac.jp

Download